JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB50516

Anti-TRIB3 antibody - Aminoterminal end

4

(3 Reviews)

|

(6 Publications)

Rabbit Polyclonal TRIB3 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human TRIB3 aa 1-50 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

C20orf97, NIPK, SKIP3, TRB3, TRIB3, Tribbles homolog 3, TRB-3, Neuronal cell death-inducible putative kinase, SINK, p65-interacting inhibitor of NF-kappa-B

1 Images
Western blot - Anti-TRIB3 antibody - Aminoterminal end (AB50516)
  • WB

Unknown

Western blot - Anti-TRIB3 antibody - Aminoterminal end (AB50516)

All lanes:

Western blot - Anti-TRIB3 antibody - Aminoterminal end (ab50516) at 1/1000 dilution

Lane 1:

HEK293 cells transfected with human TRIB3

Lane 2:

HEK293 cells (untransfected)

Lane 3:

HEK293 cells transfected with human TRIB3 with TRIB3 immunizing peptide

Secondary

All lanes:

Goat Anti-Rabbit IgG, Peroxidase conjugate

Predicted band size: 40 kDa

Observed band size: 39 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human TRIB3 aa 1-50 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

Q96RU7

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p>Staining of the TRB3 band is specifically inhibited with the immunizing peptide.</p>" }, "Cow": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab50516 is affinity purified using the immunizing peptide immobilized on agarose.
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TRIB3 also known as TRB3 or NIPK is a pseudokinase with a molecular mass of approximately 42 kDa. This protein does not possess catalytic activity. It functions largely through interactions with other proteins. TRIB3 is expressed in various tissues with high levels in the liver kidney and brain. The regulatory functions of TRIB3 involve modulating cellular processes such as stress response and apoptosis by interacting with signaling proteins.
Biological function summary

The modulation of metabolic pathways and stress responses involves TRIB3 acting in several mechanisms. While TRIB3 itself is not part of a complex it exerts its effects by binding to and inhibiting the activity of other proteins notably AKT1 and several transcription factors. This modulation influences glucose metabolism and cellular response to unfolded protein stress indicating TRIB3's role as a significant regulator of cellular homeostasis.

Pathways

The influence of TRIB3 on insulin signaling and the unfolded protein response is significant. Within the insulin signaling pathway TRIB3 interacts with AKT1 a central protein that regulates glucose uptake and cell survival. This interaction inhibits AKT1's activity impacting glucose metabolism. In the unfolded protein response pathway TRIB3 impacts stress response regulation through interactions that modulate transcriptional activity further highlighting its regulatory roles.

Alterations in TRIB3 expression and activity relate to conditions such as type 2 diabetes and cancer. In type 2 diabetes increased TRIB3 levels impair insulin signaling via AKT1 inhibition contributing to insulin resistance. In cancer the dysregulation of TRIB3 can promote survival pathways circumventing apoptosis and aiding in tumor progression. The involvement of TRIB3 in these diseases highlights its potential impact in therapeutic targeting.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Inactive protein kinase which acts as a regulator of the integrated stress response (ISR), a process for adaptation to various stress (PubMed : 15775988, PubMed : 15781252). Inhibits the transcriptional activity of DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death during ER stress (PubMed : 15775988, PubMed : 15781252). May play a role in programmed neuronal cell death but does not appear to affect non-neuronal cells (PubMed : 15775988, PubMed : 15781252). Acts as a negative feedback regulator of the ATF4-dependent transcription during the ISR : while TRIB3 expression is promoted by ATF4, TRIB3 protein interacts with ATF4 and inhibits ATF4 transcription activity (By similarity). Disrupts insulin signaling by binding directly to Akt kinases and blocking their activation (By similarity). May bind directly to and mask the 'Thr-308' phosphorylation site in AKT1 (By similarity). Interacts with the NF-kappa-B transactivator p65 RELA and inhibits its phosphorylation and thus its transcriptional activation activity (PubMed : 12736262). Interacts with MAPK kinases and regulates activation of MAP kinases (PubMed : 15299019). Can inhibit APOBEC3A editing of nuclear DNA (PubMed : 22977230).
See full target information TRIB3

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Discover oncology 15:752 PubMed39638897

2024

Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4α protein.

Applications

Unspecified application

Species

Unspecified reactive species

Si-Han Wu,Meng-Chao Xiao,Fang Liu,Huan-Yu Hong,Chen-Hong Ding,Xin Zhang,Wei-Fen Xie

Autophagy 17:1349-1366 PubMed32397857

2020

The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Pau Muñoz-Guardiola,Josefina Casas,Elisabet Megías-Roda,Sònia Solé,Héctor Perez-Montoyo,Marc Yeste-Velasco,Tatiana Erazo,Nora Diéguez-Martínez,Sergio Espinosa-Gil,Cristina Muñoz-Pinedo,Guillermo Yoldi,Jose L Abad,Miguel F Segura,Teresa Moran,Margarita Romeo,Joaquim Bosch-Barrera,Ana Oaknin,Jose Alfón,Carles Domènech,Gemma Fabriàs,Guillermo Velasco,Jose M Lizcano

Neuroscience letters 709:134352 PubMed31283965

2019

Knockdown of TRB3 improved the MPP/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Fei Hu,Mingyue Duan,Niancai Peng

Gynecologic oncology 153:425-435 PubMed30853360

2019

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Isidre Felip,Cristian Pablo Moiola,Cristina Megino-Luque,Carlos Lopez-Gil,Silvia Cabrera,Sonia Solé-Sánchez,Pau Muñoz-Guardiola,Elisabet Megias-Roda,Héctor Pérez-Montoyo,José Alfon,Marc Yeste-Velasco,María Santacana,Xavier Dolcet,Armando Reques,Ana Oaknin,Victor Rodríguez-Freixinos,José Miguel Lizcano,Carles Domènech,Antonio Gil-Moreno,Xavier Matias-Guiu,Eva Colas,Nuria Eritja

Scientific reports 6:32667 PubMed27600771

2016

Competition between members of the tribbles pseudokinase protein family shapes their interactions with mitogen activated protein kinase pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Hongtao Guan,Aban Shuaib,David Davila De Leon,Adrienn Angyal,Maria Salazar,Guillermo Velasco,Mike Holcombe,Steven K Dower,Endre Kiss-Toth

The Journal of clinical investigation 119:1359-72 PubMed19425170

2009

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells.

Applications

IP

Species

Human

María Salazar,Arkaitz Carracedo,Iñigo J Salanueva,Sonia Hernández-Tiedra,Mar Lorente,Ainara Egia,Patricia Vázquez,Cristina Blázquez,Sofía Torres,Stephane García,Jonathan Nowak,Gian María Fimia,Mauro Piacentini,Francesco Cecconi,Pier Paolo Pandolfi,Luis González-Feria,Juan L Iovanna,Manuel Guzmán,Patricia Boya,Guillermo Velasco
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com